Free Trial

Medexus Pharmaceuticals (MDP) Earnings Date, Estimates & Call Transcripts

Medexus Pharmaceuticals logo
C$2.43
+0.05 (+2.10%)
(As of 11/1/2024 ET)

Medexus Pharmaceuticals Latest Earnings Summary

Upcoming Q2
Earnings Date
Nov. 7After Market ClosesConfirmed
Actual EPS
(Aug. 7)
C$0.11 Beat By C$0.07
Consensus EPS
(Aug. 7)
C$0.04

Medexus Pharmaceuticals announced Q1 2025 earnings on August 7, 2024, reporting an EPS of C$0.11, which topped analysts' consensus estimates of C$0.04 by C$0.07. Quarterly revenue was reported to be C$37.33 million, above analyst estimates of C$36.95 million. With a trailing EPS of C$0.05 and a P/E Ratio of 48.60,

MDP Upcoming Earnings

Medexus Pharmaceuticals' next earnings date is scheduled for Thursday, November 7, 2024.

Get Medexus Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medexus Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MDP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MDP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medexus Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-C$0.08-C$0.05-C$0.07
Q2 20242-C$0.04C$0.05C$0.01
Q3 20242C$0.04C$0.12C$0.08
Q4 20242C$0.04C$0.07C$0.06
FY 20248-C$0.04C$0.19C$0.08
Q1 20253-C$0.01C$0.03C$0.00
Q2 20254-C$0.01C$0.11C$0.03
Q3 20255-C$0.01C$0.11C$0.05
Q4 20255-C$0.01C$0.12C$0.05
FY 202517-C$0.04C$0.37C$0.13
Q1 20262C$0.10C$0.23C$0.17
Q2 20262C$0.03C$0.25C$0.14
Q3 20262C$0.04C$0.25C$0.15
Q4 20262C$0.07C$0.26C$0.17
FY 20268C$0.24C$0.99C$0.62
Q1 20271C$0.11C$0.11C$0.11
Q2 20271C$0.12C$0.12C$0.12

Medexus Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Confirmed)
------- 
8/7/2024Q1 2025C$0.04C$0.11+C$0.07C$0.11C$36.95MC$37.33M
6/25/2024Q4 2024C-$0.03C$0.04+C$0.07C$0.04C$34.96MC$35.00M
2/7/2024Q3 2024C$0.10C-$0.03 -C$0.13C-$0.03C$42.33MC$34.33M
11/8/2023Q2 2024-C-$0.08 -C$0.08C-$0.09-C$40.69M
8/9/2023Q1 2024C-$0.03C$0.04+C$0.07C$0.04C$39.98MC$42.39M
6/21/2023Q4 2023C-$0.07C$0.41+C$0.48C$0.36C$38.17MC$38.72M
2/8/2023Q3 2023C-$0.09C-$0.10 -C$0.01C-$0.10C$37.16MC$39.01M
11/8/2022Q2 2023C-$0.18C-$0.19 -C$0.01C-$0.20C$30.00MC$36.13M


This page (TSE:MDP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners